The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria

Journal of Bioenergetics and Biomembranes

Volumn 44, Issue 2, 2012, Pages 273-280

  Zaccagnino, Patrizia ^a   D'Oria, Susanna ^a   Romano, Luigi Luciano ^a   Di Venere, Almerinda ^b,c   Sardanelli, Anna Maria ^a   Lorusso, Michele ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS NEUROMED   (Italy)

Author keywords

2 Arachidonoylglicerol; Cytochrome c release; Endocannabinoids; F oF 1 ATP synthase; Mitochondrial calcium overload; Mitochondrial membrane fluidity

Indexed keywords

CALCIUM; CYCLOSPORIN A; CYTOCHROME C; ENDOCANNABINOID; ENDOCANNABINOID 2 ARACHIDONOYLGLICEROL; LAURDAN; OXIDOREDUCTASE; REACTIVE OXYGEN METABOLITE; SUCCINIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL FUNCTION; CELL MEMBRANE FLUIDITY; ENZYME ACTIVITY; LIVER MITOCHONDRION; MITOCHONDRIAL MEMBRANE; NONHUMAN; POLARIZATION; PROTEIN SECRETION; RAT;

ANIMALS; APOPTOSIS; CALCIUM; CYCLOSPORINE; CYTOCHROMES C; ENDOCANNABINOIDS; IMMUNOSUPPRESSIVE AGENTS; MITOCHONDRIA, LIVER; RATS; REACTIVE OXYGEN SPECIES;

CANNABIS SATIVA; MAMMALIA;

EID: 84863863361     PISSN: 0145479X     EISSN: 15736881     Source Type: Journal    
DOI: 10.1007/s10863-012-9431-6     Document Type: Article

References (51)

1. Andreyev A, Fiskum G (1999) Calcium induced release of mitochondrial cytochrome c by different mechanisms selective for brain versus liver. Cell Death Differ 6(9):825-832. doi:10.1038/sj.cdd.4400565 (Pubitemid 29488080)
2. Basavarajappa BS (2007) Critical enzymes involved in endocannabinoid metabolism. Protein Pept Lett 14(3):237-246
3. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A et al (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163(3):463-468. doi:10.1083/jcb.200305129 (Pubitemid 37429860)
4. Broekemeier KM, Dempsey ME, Pfeiffer DR (1989) Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 264(14):7826-7830 (Pubitemid 19137258)
5. Brown AJ (2007) Novel cannabinoid receptors. Br J Pharmacol 152 (5):567-575. doi:10.1038/sj.bjp. 0707481
6. Catanzaro G, Rapino C, Oddi S, Maccarrone M (2009) Anandamide increases swelling and reduces calcium sensitivity of mitochondria. Biochem Biophys Res Commun 388(2):439-442. doi:10.1016/j.bbrc.2009.08.037
7. Chan KM, Junger KD (1984) The effect of streptozocin-induced diabetes on the plasma membrane calcium uptake activity of rat liver. Diabetes 33(11):1072-1077
8. Crompton M, Ellinger H, Costi A (1988) Inhibition by cyclosporin A of a Ca2+ -dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 255(1):357-360
9. Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34(5):605-613 (Pubitemid 19007296)
10. Di Marzo V (1998) 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim Biophys Acta 1392(2-3):153-175
11. Di Marzo V, Petrocellis LD (2006) Plant, synthetic, and endogenous cannabinoids in medicine. Annu Rev Med 57:553-574. doi:10.1146/annurev.med.57. 011205.135648 (Pubitemid 43262007)
12. Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA et al (1999) Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 264(1):258-267 (Pubitemid 29385890)
13. Di Paola M, Cocco T, Lorusso M (2000) Ceramide interaction with the respiratory chain of heart mitochondria. Biochemistry 39(22):6660-6668 (Pubitemid 30353998)
14. Di Paola M, Zaccagnino P, Oliveros-Celis C, Lorusso M (2006) Arachidonic acid induces specific membrane permeability increase in heart mitochondria. FEBS Lett 580(3):775-781. doi:10.1016/j.febslet.2005.12.090 (Pubitemid 43152296)
15. Franklin A, Parmentier-Batteur S, Walter L, Greenberg DA, Stella N (2003) Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J Neurosci 23(21):7767-7775 (Pubitemid 37052344)
16. Gaoni Y, Mechoulam R (1971) The isolation and structure of delta-1- tetrahydrocannabinol and other neutral cannabinoids from hashish. J Am Chem Soc 93(1):217-224
17. Halestrap AP, Davidson AM (1990) Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 268(1):153-160 (Pubitemid 20166664)
18. Hansson MJ, Mansson R, Morota S, Uchino H, Kallur T, Sumi T et al (2008) Calcium-induced generation of reactive oxygen species in brain mitochondria is mediated by permeability transition. Free Radic Biol Med 45(3):284-294. doi:S0891-5849(08)00208-6
19. Ito A, Ogishima T, Ou W, Omura T, Aoyagi H, Lee S et al (1985) Effects of synthetic model peptides resembling the extension peptides of mitochondrial enzyme precursors on import of the precursors into mitochondria. J Biochem 98(6):1571-1582 (Pubitemid 16169191)
20. Izzo AA, Fezza F, Capasso R, Bisogno T, Pinto L, Iuvone T et al (2001) Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br J Pharmacol 134(3):563-570. doi:10.1038/sj.bjp. 0704293
21. Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M et al (2005) Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128(3):742-755 (Pubitemid 40585376)
22. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M (2009) Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89(1):309-380. doi:10.1152/physrev.00019.2008
23. Kondo S, Kondo H, Nakane S, Kodaka T, Tokumura A, Waku K et al (1998) 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through CA2+ -dependent and -independent mechanisms. FEBS Lett 429(2):152-156 (Pubitemid 28288200)
24. Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG, Cosenza V et al (2003) Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 125(3):677-687 (Pubitemid 37070686)
25. Maciel EN, Vercesi AE, Castilho RF (2001) Oxidative stress in Ca(2+)-induced membrane permeability transition in brain mitochondria. J Neurochem 79(6):1237-1245 (Pubitemid 34019801)
26. Martin BR (1986) Cellular effects of cannabinoids. Pharmacol Rev 38(1):45-74
27. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346(6284):561-564. doi:10.1038/346561a0
28. McStay GP, Clarke SJ, Halestrap AP (2002) Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem J 367(Pt 2):541-548. doi:10.1042/BJ20011672 (Pubitemid 35216831)
29. Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M et al (2000) Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 141(1):118-126 (Pubitemid 32260350)
30. Mukherjee S, Adams M, Whiteaker K, Daza A, Kage K, Cassar S et al (2004) Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors. Eur J Pharmacol 505(1-3):1-9. doi:10.1016/j.ejphar.2004. 09.058 (Pubitemid 39535670)
31. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (6441):61-65. doi:10.1038/365061a0 (Pubitemid 23305569)
32. Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58(3):389-462. doi:10.1124/pr.58.3.2 (Pubitemid 44394908)
33. Palleschi S, Silvestroni L (1996) Laurdan fluorescence spectroscopy reveals a single liquid-crystalline lipid phase and lack of thermotropic phase transitions in the plasma membrane of living human sperm. Biochim Biophys Acta 1279(2):197-202 (Pubitemid 26080850)
34. Patel SP, Katyare SS (2006a) Effect of alloxan diabetes and subsequent insulin treatment on temperature kinetics properties of succinate oxidase activity in rat kidney mitochondria. J Membr Biol 213 (1):31-37. doi:10.1007/s00232-006-0041-2 (Pubitemid 46440140)
35. Patel SP, Katyare SS (2006b) Insulin-status-dependent modulation of FoF1-ATPase activity in rat liver mitochondria. Lipids 41(7):695-703 (Pubitemid 44547684)
36. Pinto L, Izzo AA, Cascio MG, Bisogno T, Hospodar-Scott K, Brown DR et al (2002) Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology 123(1):227-234 (Pubitemid 34747543)
37. Piomelli D (2005) The endocannabinoid system: a drug discovery perspective. Curr Opin Investig Drugs 6(7):672-679
38. Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J et al (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152(7):1092-1101. doi:10.1038/sj.bjp. 0707460
39. Schmid PC, Schwartz KD, Smith CN, Krebsbach RJ, Berdyshev EV, Schmid HH (2000) A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols. Chem Phys Lipids 104(2):185-191
40. Schonfeld P, Wojtczak L (2007) Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport. Biochim Biophys Acta 1767(8):1032-1040. doi:10.1016/j.bbabio.2007.04.005 (Pubitemid 47101786)
41. Siegmund SV, Qian T, deMinicis S, Harvey-White J, Kunos G, Vinod KY et al (2007) The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J 21(11):2798-2806. doi:10.1096/fj.06-7717com (Pubitemid 47372747)
42. Sipe JC, Arbour N, Gerber A, Beutler E (2005) Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J Leukoc Biol 78(1):231-238. doi:10.1189/jlb.0205111 (Pubitemid 40979962)
43. Spector AA, Yorek MA (1985) Membrane lipid composition and cellular function. J Lipid Res 26(9):1015-1035 (Pubitemid 16258287)
44. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 (6644):773-778. doi:10.1038/42015 (Pubitemid 27375156)
45. Studer RK, Ganas L (1989) Effect of diabetes on hormone-stimulated and basal hepatocyte calcium metabolism. Endocrinology 125 (5):2421-2433 (Pubitemid 19279427)
46. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K et al (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215(1):89-97
47. Thomas BF, Compton DR, Martin BR (1990) Characterization of the lipophilicity of natural and synthetic analogs of delta 9- tetrahydrocannabinol and its relationship to pharmacological potency. J Pharmacol Exp Ther 255(2):624-630
48. Wang J, Ueda N (2009) Biology of endocannabinoid synthesis system. Prostaglandins Other Lipid Mediat 89(3-4):112-119. doi:10.1016/j.prostaglandins. 2008.12.002
49. Zaccagnino P, Saltarella M, D'Oria S, Corcelli A, Saponetti MS, Lorusso M (2009) N-arachidonylglycine causes ROS production and cytochrome c release in liver mitochondria. Free Radic Biol Med 47(5):585-592. doi:10.1016/j. freeradbiomed.2009.05.038
50. Zaccagnino P, Corcelli A, Baronio M, Lorusso M (2011) Anandamide inhibits oxidative phosphorylation in isolated liver mitochondria. FEBS Lett 585(2):429-434. doi:10.1016/j.febslet.2010.12.032
51. Zias J, Stark H, Sellgman J, Levy R, Werker E, Breuer A et al (1993) Early medical use of cannabis. Nature 363(6426):215. doi:10.1038/363215a0